Paul Tesar, a professor of genetics and genome sciences and the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics at Case Western Reserve University’s School of Medicine, is among 20 researchers nationally to receive a R35 Research Program Award (RPA) from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health (NIH).

Tesar was recognized for his work in modulating glial fate and function in development and disease.

The newest group of R35 RPA scientists represents a range of neuroscience research interests, including understanding the mechanisms of hemorrhagic stroke; taking a detailed look at how motor circuits are put together; developing strategies to improve remyelination in multiple sclerosis; and identifying new cerebellar functions.

The list of 20 recipients includes researchers from Brown University, New York University School of Medicine, University of Chicago and University of Pennsylvania.  

The RPA launched in 2015 as an alternative to the R01, the Research Project Grant (RPG), which makes up most NIH grants. RPGs typically last between three and five years and are awarded to support a single specific project idea.